Daliresp
roflumilast
- Strength
- 500 ug/1
- Form
- Tablet
- Class
- Phosphodiesterase 4 Inhibitor
AstraZeneca Pharmaceuticals LP
ZORYVE
roflumilast
Listed by Arcutis Biotherapeutics, Inc.
- Strength
- 3 mg/g
- Form
- Aerosol, Foam
- Route
- Topical
- Class
- Phosphodiesterase 4 Inhibitor
What it contains
- Roflumilast 3 mg/g
FDA record
| Dosage form | Aerosol, Foam |
|---|---|
| Route | Topical |
| Drug class | Phosphodiesterase 4 Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 80610-430 |
| FDA application | NDA217242 |
| RxNorm concept | 2671682 |
| Package sizes listed | 1 |
| Marketed since | December 2023 |
Other products containing Roflumilast
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Daliresp
roflumilast
- Strength
- 250 ug/1
- Form
- Tablet
- Class
- Phosphodiesterase 4 Inhibitor
AstraZeneca Pharmaceuticals LP
Roflumilast
- Strength
- 250 ug/1
- Form
- Tablet
- Class
- Phosphodiesterase 4 Inhibitor
Camber Pharmaceuticals, Inc.
ROFLUMILAST
- Strength
- 500 ug/1
- Form
- Tablet
- Class
- Phosphodiesterase 4 Inhibitor
Micro Labs Limited
ROFLUMILAST
- Strength
- 250 ug/1
- Form
- Tablet
- Class
- Phosphodiesterase 4 Inhibitor
Aurobindo Pharma Limited
Roflumilast
- Strength
- 250 ug/1
- Form
- Tablet
- Class
- Phosphodiesterase 4 Inhibitor
Novadoz Pharmaceuticals LLC
Roflumilast
- Strength
- 500 ug/1
- Form
- Tablet
- Class
- Phosphodiesterase 4 Inhibitor
MAJOR PHARMACEUTICALS
Roflumilast
- Strength
- 500 ug/1
- Form
- Tablet
- Class
- Phosphodiesterase 4 Inhibitor
Camber Pharmaceuticals, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.